OSTEONIC Co., Ltd.

OSTEONIC Co., Ltd.

KKRX:226400
4,170.00
KRW
+20.00
(+0.48%)
571.50EPS
7.18P/E
83.55BMarket Cap
Nov 17Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
829.4
768.99
925.16
1,091.89
768.41
880.14
996.38
1,000.94
1,187.18
1,466.79
1,726.99
2,263.99
2,899.23
Basic EPS, GAAP
92.67
102.67
214.67
-542.67
-561.33
39.32
-425
-183
50
193
285
374
580.42
Free Cash Flow per Basic Share
-178.21
-536.72
-686.68
-414.34
-572.83
-796.43
-41.56
-56.2
100.46
-149.47
-117.65
3.25
-170.27
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
90.08
727.44
1,492.94
949.44
2,247.18
2,283.43
1,880.1
2,106.64
2,190.19
2,619.79
2,995.89
3,362.65
3,585.82
Tangible Book Value per Share
88.84
673.67
942.6
274.02
1,971.87
1,986.45
1,658.05
1,820.64
1,895.84
2,395.77
2,738.88
3,160.28
3,299.48
Basic Weighted Avg Shares
3
5
7
8
12
13
13
16
17
19
20
20
18
Sales/Revenue/Turnover
2,581
3,507
6,640
8,540
9,085
11,161
12,615
15,598
19,839
27,799
34,235
45,393
50,972
Operating Margin (%)
13.28
8.57
22.19
26.01
1.49
4.3
1.81
3.71
12.73
17.42
20.11
19.53
18.38
Depreciation Expense
144
216
480
714
949
2,285
2,434
2,213
2,415
2,707
3,419
3,695
3,900
Net Income, GAAP
288
468
1,541
-4,245
-6,637
499
-5,381
-2,852
836
3,658
5,650
7,499
10,204
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
59.85
- -
14.9
11.01
14.29
Profit Margin (%)
11.17
13.35
23.2
-49.7
-73.05
4.47
-42.65
-18.28
4.21
13.16
16.5
16.52
20.02
Working Capital
1,694
4,539
5,199
4,443
24,017
20,832
21,914
15,526
17,737
28,370
36,148
38,897
35,349
LT Debt
1,827
1,089
2,497
4,620
7,816
10,175
9,201
2
1,727
3,506
7,815
6,479
6,953
Total Equity
705
5,690
11,678
7,427
28,497
28,957
24,281
35,532
36,501
51,877
59,324
67,577
72,051
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
2.13
- -
8.3
9.39
8.76
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
2.77
- -
9.07
10.14
12.24
Return on Common Equity (%)
- -
14.65
17.74
-44.44
-36.95
1.74
-20.21
-9.54
2.32
8.28
10.16
11.83
15.25

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
15,297
21,844
22,106
LT Borrowings
4,250
3,900
3,900
LT Finance Leases
2,229
2,242
3,053
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
124,780
125,382
83,555

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
58,710
61,784
63,162
Cash, Cash Equivalents & STI
21,535
20,613
21,336
Accounts Receivable, Net
16,781
17,059
16,386
Inventories
19,441
21,958
23,511
Total Current Liabilities
19,813
28,344
27,813
Payables & Accruals
- -
- -
- -
ST Debt
15,297
21,844
22,106
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
45.75%
23.89%
13.91%
Free Cash Flow
-48.4%
-122.89%
-102.79%
Net Income, GAAP
-112.79%
49.73%
32.73%
Sales/Revenue/Turnover
30.69%
29.34%
32.59%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7,694
8,646
8,164
9,731
34,235
2025
9,529
10,977
11,878
13,010
45,393
2026
12,901
13,183
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
82
63
138.41
285
2025
38
51
195.13
186.36
374
2026
132.41
91
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Dong-Won Lee
Full Time Employees
197
Sector
Health technology
Industry
Medical specialties
Address
Seoul South Korea
IPO Date
May 4, 2016
Business
OSTEONIC Co., Ltd. is a South Korea-based medical device manufacturer specializing in the development, design, and commercialization of surgical implants, biomaterials, and precision orthopedic fixation systems. Founded in 2012 and headquartered in Seoul, South Korea, the company operates across five core medical sectors: Cranio-Maxillofacial (CMF), Trauma and Extremities, Sports Medicine, Spine, and Dental surgery. OSTEONIC offers a comprehensive range of metal and biodegradable polymer implants, including the Optimus CMF System and Biobsorb Plating System for cranial, mandibular, orthognathic, and facial reconstructive surgery; the SIGNEX and Quantum Trauma Systems, comprising anatomically contoured titanium locking and non-locking compression plates, cannulated screws, and headless compression screws for upper and lower extremity fractures, hand, wrist, clavicle, foot, and ankle stabilization; the Kinex Sports Medicine portfolio, featuring biodegradable composite suture anchors, interference screws, and tendon-to-bone fixation devices for ligament repair; Anterior Cervical Plating (ACP) and spinal fixation implants; the Optimus D dental fixation line, including palatal plates, mandible compression screws, and oral surgical kits; custom 3D-designed patient-specific cranial implants under the Real Fit brand; and specialized surgical instrumentation kits and screwdriver systems for orthopedic and reconstructive procedures. The company serves hospitals, surgical clinics, and healthcare networks globally across North America, Europe, the Asia-Pacific, and Latin America through proprietary brand distribution and international OEM/ODM partnerships with multinational medical corporations, including B. Braun Aesculap for neurosurgical plating systems and Zimmer Biomet for sports medicine implants. In recent developments, OSTEONIC expanded its strategic manufacturing and distribution partnership with Zimmer Biomet to develop and supply the Suture Passer surgical instrument, securing South Korean Ministry of Food and Drug Safety approval alongside U.S. FDA 510(k) submission for global commercialization. The company has also secured multiple FDA clearances across its trauma, spinal ACP, and biocomposite product portfolios and completed a significant manufacturing facility expansion to scale annual production capacity across both metal and bioabsorbable implant lines to meet expanding international export demand.